Drug Information Association (DIA) Canada Annual Meeting

Drug Information Association (DIA) Canada Annual Meeting is organized by Drug Information Association (DIA) and will be held from Oct 27 - 28, 2025 at Hilton Lac Leamy, Gatineau, Quebec, Canada.

Description:
The DIA Canada Annual Meeting will provide an in-depth exploration of the current pharmaceutical, medical device, and diagnostic landscapes in Canada, emphasizing Canada’s pivotal role in global healthcare product development. Offering three specialized tracks on Regulatory, Clinical, and Safety and Pharmacovigilance, the meeting will cover topics spanning from Health Canada’s latest regulatory initiatives, international collaboration, and innovative clinical practices to approaches that harness AI in drug safety and increase representation from equity-denied groups.

Attendees will have the opportunity to engage with leaders and experts from academia, regulatory bodies, and the pharmaceutical and medical device industries by gaining insights into best practices, lessons learned, and strategies to address the challenges facing stakeholders in Canada.

Learning Objectives:
At the conclusion of this meeting, participants should be able to:

• Describe Health Canada’s evolving regulatory priorities and their role in advancing global collaboration and public health
• Recognize trends in clinical research modernization, including patient engagement, trial accessibility, and innovative study approaches
• Identify current and emerging frameworks in safety and pharmacovigilance that support compliance, data quality, and patient protection
• Assess the impact of international and multi-stakeholder collaboration on regulatory innovation, clinical trials, and patient access
• Discuss the role of technology and digital transformation (e.g., AI, automation, data-driven submissions) in shaping the future of regulatory affairs, safety, and clinical development
• Explore strategies for workforce and professional development to strengthen Canada’s position in the global research and regulatory ecosystem